Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cryptosporidium dose response studies: variation between isolates.

Peter F M Teunis1, Cynthia L Chappell, Pablo C Okhuysen

  • 1National Institute for Public Health and the Environment, Bilthoven, The Netherlands. Peter.Teunis@rivm.nl

Risk Analysis : an Official Publication of the Society for Risk Analysis
|May 23, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seroresponse to repeated infections with Salmonella enterica Typhi and Paratyphi A.

Epidemics·2025
Same author

Bezlotoxumab for the prevention of recurrent <i>Clostridioides difficile</i> infection for patients with cancer.

Annals of gastroenterology·2025
Same author

Ten Practical Tips for a Successful Presentation at an Infectious Disease Clinical Case Conference.

Open forum infectious diseases·2025
Same author

The impact of cancer-related diarrhea on changes in cancer therapy.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2024
Same author

Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host disease.

Cell host & microbe·2024
Same author

A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2024

Human feeding studies revealed significant differences in Cryptosporidium parvum infectivity among three isolates. This highlights the importance of considering isolate variation for accurate Cryptosporidium parvum risk assessment.

Area of Science:

  • Parasitology
  • Infectious Diseases
  • Public Health

Background:

  • Cryptosporidium parvum is a significant waterborne protozoan parasite causing human illness.
  • Understanding the dose-response relationship is crucial for public health risk assessment.
  • Previous studies have suggested potential variations in infectivity, but direct human data is limited.

Purpose of the Study:

  • To quantify the infectivity of different Cryptosporidium parvum isolates in humans.
  • To determine the variation in infectious dose 50% (ID50) among isolates.
  • To provide evidence for heterogeneity in Cryptosporidium parvum infectivity for quantitative risk assessment.

Main Methods:

  • Human feeding studies were conducted using three distinct isolates of Cryptosporidium parvum (Iowa, TAMU, UCP).

Related Experiment Videos

  • The infectious dose 50% (ID50) was determined for each isolate.
  • Data was analyzed to assess the statistical significance of infectivity differences.

    • Main Results:

    • Significant variation in infectivity was observed among the three Cryptosporidium parvum isolates.
    • The determined ID50 values differed substantially between the Iowa, TAMU, and UCP isolates.
    • This demonstrates heterogeneity in the infectivity of Cryptosporidium parvum for the human host.

    Conclusions:

    • Isolate-specific infectivity is a critical factor in Cryptosporidium parvum infections.
    • Findings support the need to incorporate isolate variability into quantitative risk assessments for waterborne pathogens.
    • This research has implications for public health strategies and water quality guidelines.